Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Orexigen Therapeutics Still a Good Buy?
Seeking Alpha
Monday, February 7, 2011 - 11:27am
tags:
obesity, Orexigen, Contrave
Targacept, AstraZeneca begin new trial
Bizjournals.com
Monday, February 7, 2011 - 11:21am
tags:
AstraZeneca, Targacept, TC-5214, major depressive disorder
Earnings Preview: MannKind
Yahoo/Zacks.com
Monday, February 7, 2011 - 11:19am
tags:
earnings, MannKind
Action Date for AZN's Brilinta
Yahoo/Zacks.com
Monday, February 7, 2011 - 11:18am
tags:
AstraZeneca, Brilinta
Crucell takes 4Q loss as sales fall
Yahoo/AP
Monday, February 7, 2011 - 11:18am
tags:
earnings, Crucell
Lilly Ties Employee Bonus To R&D Pipeline
Pharmalot
Monday, February 7, 2011 - 8:45am
tags:
Eli Lilly, bonuses, R&D
KV gets boost from FDA approval of prenatal drug
St Louis Dispatch, MO
Monday, February 7, 2011 - 8:44am
tags:
FDA, KV Pharmaceutical, Makena, premature birth, Hologic
Finish Line Nears for Sanofi-Genzyme Talks
NY Times, NY
Monday, February 7, 2011 - 8:41am
tags:
M&A, Sanofi, Genzyme
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations
Seeking Alpha
Monday, February 7, 2011 - 8:01am
tags:
JNJ, GSK, Pfizer, Teva Pharmaceuticals, Actelion
New Hurdle for Orexigen Diet Pill Has Investors Worried
Seeking Alpha
Monday, February 7, 2011 - 7:56am
tags:
Orexigen, obesity, Contrave, FDA
Pfizer will buy Ferrosan consumer health business
Yahoo/AP
Monday, February 7, 2011 - 7:54am
tags:
Pfizer, Ferrosan, M&A
AstraZeneca halts prostrate cancer drug trial
Marketwatch
Monday, February 7, 2011 - 7:52am
tags:
AstraZeneca, prostate cancer, zibotentan
Pfizer Looks to Partners as It Narrows Therapeutic Focus
Seeking Alpha
Monday, February 7, 2011 - 7:51am
tags:
Pfizer, M&A
Sanofi, Genzyme Work Toward Deal
TheStreet.com
Monday, February 7, 2011 - 7:50am
tags:
Sanofi, M&A, Genzyme
"Big Pharma has Created Wealth, While Biotech has Destroyed Wealth"
PRLog
Saturday, February 5, 2011 - 11:51am
tags:
Big Pharma
Pfizer & Takeda enter co-promotion agreements for rheumatoid arthritis products in Japan
pharmabiz
Saturday, February 5, 2011 - 11:47am
tags:
Pfizer, Takeda, Enbrel, tasocitinib, CP-690, 550, rheumatoid arthritis
Sanofi could sweeten bid for Genzyme before next Wednesday: Report
International Business Times
Saturday, February 5, 2011 - 11:45am
tags:
Sanofi, M&A, Genzyme
Perrigo Excels, Lifts Outlook
Yahoo/Zacks
Saturday, February 5, 2011 - 11:10am
tags:
Perrigo Company
Lilly Will Tie Bonuses to Drug Development in Face of Generic Competition
Bloomberg
Saturday, February 5, 2011 - 11:08am
tags:
Eli Lilly
Risperdal Overcharge Trial Looms Over J&J
The Street
Saturday, February 5, 2011 - 11:07am
tags:
JNJ, Risperdal, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.